# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001558370-24-006020
Filing Date
2024-04-29
Accepted
2024-04-29 09:25:17
Documents
42
Period of Report
2024-04-29
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | capr-20240429x8k.htm iXBRL | 8-K | 37682
2 | EX-99.1 | capr-20240429xex99d1.htm | EX-99.1 | 133186
3 | GRAPHIC | capr-20240429xex99d1g001.jpg | GRAPHIC | 56715
4 | GRAPHIC | capr-20240429xex99d1g002.jpg | GRAPHIC | 189603
5 | GRAPHIC | capr-20240429xex99d1g003.jpg | GRAPHIC | 54811
6 | GRAPHIC | capr-20240429xex99d1g004.jpg | GRAPHIC | 67402
7 | GRAPHIC | capr-20240429xex99d1g005.jpg | GRAPHIC | 86799
8 | GRAPHIC | capr-20240429xex99d1g006.jpg | GRAPHIC | 118398
9 | GRAPHIC | capr-20240429xex99d1g007.jpg | GRAPHIC | 95867
10 | GRAPHIC | capr-20240429xex99d1g008.jpg | GRAPHIC | 89716
11 | GRAPHIC | capr-20240429xex99d1g009.jpg | GRAPHIC | 75093
12 | GRAPHIC | capr-20240429xex99d1g010.jpg | GRAPHIC | 65865
13 | GRAPHIC | capr-20240429xex99d1g011.jpg | GRAPHIC | 67903
14 | GRAPHIC | capr-20240429xex99d1g012.jpg | GRAPHIC | 89274
15 | GRAPHIC | capr-20240429xex99d1g013.jpg | GRAPHIC | 84448
16 | GRAPHIC | capr-20240429xex99d1g014.jpg | GRAPHIC | 67709
17 | GRAPHIC | capr-20240429xex99d1g015.jpg | GRAPHIC | 83697
18 | GRAPHIC | capr-20240429xex99d1g016.jpg | GRAPHIC | 96057
19 | GRAPHIC | capr-20240429xex99d1g017.jpg | GRAPHIC | 100405
20 | GRAPHIC | capr-20240429xex99d1g018.jpg | GRAPHIC | 86828
21 | GRAPHIC | capr-20240429xex99d1g019.jpg | GRAPHIC | 84031
22 | GRAPHIC | capr-20240429xex99d1g020.jpg | GRAPHIC | 161450
23 | GRAPHIC | capr-20240429xex99d1g021.jpg | GRAPHIC | 68086
24 | GRAPHIC | capr-20240429xex99d1g022.jpg | GRAPHIC | 96238
25 | GRAPHIC | capr-20240429xex99d1g023.jpg | GRAPHIC | 70750
26 | GRAPHIC | capr-20240429xex99d1g024.jpg | GRAPHIC | 103929
27 | GRAPHIC | capr-20240429xex99d1g025.jpg | GRAPHIC | 71377
28 | GRAPHIC | capr-20240429xex99d1g026.jpg | GRAPHIC | 68339
29 | GRAPHIC | capr-20240429xex99d1g027.jpg | GRAPHIC | 91962
30 | GRAPHIC | capr-20240429xex99d1g028.jpg | GRAPHIC | 74551
| Complete submission text file | 0001558370-24-006020.txt |  | 3705480

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
31 | EX-101.SCH | capr-20240429.xsd | EX-101.SCH | 3120
32 | EX-101.LAB | capr-20240429_lab.xml | EX-101.LAB | 15266
33 | EX-101.PRE | capr-20240429_pre.xml | EX-101.PRE | 9654
45 | EXTRACTED XBRL INSTANCE DOCUMENT | capr-20240429x8k_htm.xml | XML | 4682

Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34058 | Film No.: 24887165
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)